Nutrition for inherited metabolic disorders

Powdered Formulas

NutrigenNutrigen
Nutrigen

Specialized therapeutic nutrition for patients with phenylketonuria and inherited amino acid metabolism disorders

AfenilakAfenilak
Afenilak

Specialized therapeutic nutrition products for patients with phenylketonuria

Dietary therapy for a full life

A complete range of specialized products for children from birth and adults with rare inherited metabolic disorders.

Free from phenylalanine

Therapeutic amino acid-based products are well tolerated by patients and provide a positive therapeutic effect.

People with rare inherited metabolic disorders require therapeutic products that meet dietary needs for amino acids at every age.

Dietary therapy is one of the leading methods of pathogenetic treatment for inherited metabolic disorders. The comprehensive range of domestic dietary products under the Nutrigen brand has been developed in accordance with modern requirements for the quality and safety of therapeutic nutrition.

The use of specialized products provides broad opportunities for adequate dietary management of patients with inherited metabolic disorders.

Interesting facts:

Infaprim has been a trusted producer of infant nutrition products for 20 years.
1 / 3

01

The Nutrigen line includes over 30 products for children and adults.

02

Used for rare inherited disorders such as phenylketonuria, maple syrup urine disease, tyrosinemia, and others.

03

Included in the list of therapeutic nutrition products for children with disabilities.

Latest news

17.07.2026A Strategic Step Toward Russia’s Full Self-Sufficiency in Enteral Nutrition

Zafar Azimov Personally Oversees Construction of Enteral Nutrition Production Facility in Istra

17.07.2026Supporting the Professional Development of Medical Specialists

Infaprim, in partnership with the Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology (FRCC ICMR) and K+31 Medical Center, organized a three-day masterclass entitled “Nutritional Support for Patients with Acute Cerebrovascular Accident at All Stages of Rehabilitation”

09.02.2026Production expansion — new opportunities for patients

We continue to implement a large –scale project to modernize enteral nutrition production.

09.02.2026Nutrilak Premium Pre 0 – a new product for low-birth –weight babies

Premature infants and babies born with low birth weight need especially gentle care and targeted nutritional support during the earliest stages of life.

16.06.2025Nutrilak Premium PEPTIDI MSC has been discontinued

It has been replaced by a more advanced formula with similar indications – Nutrilak Premium GASTRO PEP.